A Social Media Question IRBs Must Ask

updated May 10, 2012by
Thumbnail image for A Social Media Question IRBs Must Ask

I don’t envy IRBs. In the absence of clear guidance on social media and patient recruitment, they are in a difficult spot. Despite the difficulty, the solution is not to hope social media goes away. It won’t. Internet users have developed a taste for dynamic interactive content, and they have [...]

Read the full article →

My Awesome Cajun Code Fest Experience (And What It Means For Clinical Research)

updated May 3, 2012by
Thumbnail image for My Awesome Cajun Code Fest Experience (And What It Means For Clinical Research)

At 8am on Friday morning, I anxiously sat around a table with a group of people I had just met. I’d be spending the next 48 hours with them, and I had no idea what to expect. The event would be unlike anything I’d ever experienced. But I knew one [...]

Read the full article →

Can “Keystone Habits” Create Pharma Innovation?

updated April 13, 2012by
Thumbnail image for Can “Keystone Habits” Create Pharma Innovation?

As I was recently browsing my Linkedin feed, I saw a PharmExec article titled “Innovation: Why is Pharma Scared to Death?” The article had this to say about pharma’s innovation problem: The missing ingredient is courage. (And no, it’s not because the FDA won’t let companies be courageous. Being a [...]

Read the full article →

The Secret to Improving Patient Compliance With Habit

updated April 30, 2012by
Thumbnail image for The Secret to Improving Patient Compliance With Habit

UPDATE: I recently did a interview on this topic with Natalie Morrison of Outsourcing Pharma. Listen to the podcast here: Improve Patent Compliance By Designing Trials Around Real Life. I try to provide my newsletter readers with something extra that is not available publicly on the Rebar Interactive website. This [...]

Read the full article →

Is Pfizer’s Virtual Clinical Trial Model a Failure?

updated April 6, 2012by
Thumbnail image for Is Pfizer’s Virtual Clinical Trial Model a Failure?

In a recent article in Outsourcing Pharma, Nick Taylor detailed a big setback to Pfizer’s virtual clinical trial. According to Miguel Orri, senior director of clinical sciences at Pfizer, “it didn’t recruit.” Orri added, “problems stemmed from a failure, possibly caused by the team’s regulatory focus, to appreciate what patients [...]

Read the full article →

One Detail Clinical Researchers Must Know About Social Media

updated February 29, 2012by
Thumbnail image for One Detail Clinical Researchers Must Know About Social Media

I want to apologize to clinical research professionals who regularly read this blog. You are about to hear a message you’ve heard from me several times. But I think spreading this message is essential if the clinical research industry is to harness the potential of digital patient recruitment. I have [...]

Read the full article →

Digital Marketing for Patient Recruitment: 4 Benefits and 3 Challenges

updated February 14, 2012by
Thumbnail image for Digital Marketing for Patient Recruitment: 4 Benefits and 3 Challenges

Though still in relative infancy, digital media has significantly impacted the business world. It led to the meteoric rise of companies like Google and Facebook. And it’s also responsible for the struggles of Kodak, a once iconic (and seemingly invincible) brand. No one can predict exactly what changes digital media [...]

Read the full article →

Geo-Social Networking Sites for Patient Recruitment

updated February 2, 2012by
Thumbnail image for Geo-Social Networking Sites for Patient Recruitment

I was doing research on clinical site use of geo social networking and found that very few clinical sites actively use it. In fact, Clinical Trials of Texas was the only clinical site I found to be making strategic use of geo social networking. So I asked CTT to share [...]

Read the full article →

Electronic Informed Consent: Types and Technologies

updated April 2, 2012by
Thumbnail image for Electronic Informed Consent: Types and Technologies

Wondering if electronic informed consent is right for your clinical research study? My 2-part series will help you answer that question. Mitchell Parrish of Quorum IRB recently led a webinar about electronic informed consent, which included discussion of regulatory and other considerations. In this series, I summarize the information presented [...]

Read the full article →

Electronic Informed Consent: Possibilities, Benefits, and Challenges

updated April 2, 2012by
Thumbnail image for Electronic Informed Consent: Possibilities, Benefits, and Challenges

The clinical research community is showing greater interest in electronic informed consent. And they should. Electronic consenting offers benefits that traditional paper-based consenting does not. But with electronic consenting technology comes new complexity. To address the regulatory and IRB complexity of electronic consenting, Quorum Review IRB recently hosted a webinar [...]

Read the full article →

← Previous Entries